查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1542923

全球骨骼生长刺激剂市场 - 2024-2031

Global Bone Growth Stimulators Market - 2024-2031
出版日期: | 出版商: DataM Intelligence | 英文 182 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

市场概况

全球骨骼生长刺激剂市场在2023年达到16.4亿美元，预计到2031年将达到244万美元，在2024-2031年预测期间复合年增长率为5.1%。

骨骼生长刺激剂可以改善接受骨融合手术的患者的身体骨癒合过程。这些刺激器可以穿戴在室外或在植入治疗期间使用，例如心臟再同步治疗 (CRT) 和植入式心律转復除颤器 (ICD)。它可以透过施加电波或超音波来治癒骨折。这种非侵入性骨癒合治疗方法是骨移植的替代方法。

该市场的成长是由于对微创治疗的日益偏好、骨折和脊柱损伤病例的增加、老年人口的增加以及随之而来的骨科疾病和损伤病例的增加以及运动损伤发生率的增加而推动的。

此外，全球医院和手术中心数量的不断增加、血小板和富血浆（PRP）在其他应用中的利用率不断增加以及新兴经济体为该市场的成长提供了机会。

市场动态：

司机

对非侵入性和微创手术治疗的需求不断增长

全球骨生长刺激剂市场的需求是由多种因素所驱动的。关键因素之一是，患者越来越多地选择非侵入性和微创手术治疗，因为它们比传统手术有好处，例如併发症更少、住院时间更短、疼痛减轻、感染风险更低和恢復更快。

此外，该行业的主要参与者推出了创新平台和技术，以推动该市场的成长。例如，2023 年 5 月，专门从事脊椎和骨科解决方案的知名公司 Orthofix Medical Inc. 宣布，其 STIM onTrack 行动应用程式荣获 MedTech Breakthrough 颁发的「最佳患者参与行动应用程式」奖。

此外，2023 年 4 月，脊椎和骨科领域的知名公司 Orthofix Medical 推出了两款专为微创脊椎 (MIS) 手术量身定制的通路牵开器系统。 Lattus 侧入路系统和 Fathom 椎弓根牵开器系统的推出升级了该公司的入路解决方案组合。

限制

产品召回、高昂的治疗和诊断成本、严格的审批程序、有限的医疗报销政策、基于 BMP 的治疗的副作用以及人们的认识有限等因素预计将阻碍市场。

目录

第 1 章：方法与范围

第 2 章：定义与概述

第 3 章：执行摘要

第 4 章：动力学

  • 影响因素
    • 司机
      • 对非侵入性和微创手术治疗的需求不断增长
      • 医疗保健技术进步
      • 老年人口增加
      • 骨骼和关节疾病的负担不断增加
      • 运动和事故相关的骨科损伤数量不断增加
    • 限制
      • 产品召回
      • 治疗和诊断费用高
    • 机会
    • 影响分析

第 5 章：产业分析

  • 波特五力分析
  • 供应链分析
  • 定价分析
  • 监管分析
  • 未满足的需求
  • PESTEL分析
  • 专利分析
  • SWOT分析

第 6 章：COVID-19 分析

第 7 章：副产品

  • 植入骨生长刺激器
  • 超音波骨生长刺激器
  • 外部骨骼生长刺激器（组合磁场 (CMF) 设备）
  • 脉衝电磁场 (PEMF) 设备
  • 电容耦合 (CC) 装置）
  • 非侵入性骨生长刺激器
  • 侵入性骨生长刺激剂
  • 其他的

第 8 章：按申请

  • 脊椎融合手术
  • 外伤和骨折
  • 成骨
  • 口腔颚面外科
  • 延迟癒合和骨不连骨折
  • 其他的

第 9 章：最终用户

  • 骨科诊所
  • 医院
  • 门诊手术中心
  • 学术及研究机构
  • 居家护理
  • 其他的

第 10 章：按地区

  • 北美洲
    • 我们
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 义大利
    • 西班牙
    • 欧洲其他地区
  • 南美洲
    • 巴西
    • 阿根廷
    • 南美洲其他地区
  • 亚太
    • 中国
    • 印度
    • 日本
    • 韩国
    • 亚太其他地区
  • 中东和非洲

第 11 章：竞争格局

  • 竞争场景
  • 市场定位/份额分析
  • 併购分析

第 12 章：公司简介

  • Zimmer Biomet
    • 公司概况
    • 产品组合和描述
    • 财务概览
    • 主要进展
  • Orthofix Medical Inc
  • Enovis Corporation
  • ZimVie Inc
  • OssaTechnics
  • Kinex Medical Company, LLC
  • VQ OrthoCare
  • SIG Orthopaedic
  • Elizur
  • IGEA SpA (LIST NOT EXHAUSTIVE)

第 13 章：附录

简介目录
Product Code: MD1278

Market Overview

The Global Bone Growth Stimulators Market reached US$ 1.64 billion in 2023 and is expected to reach US$ 2.44 million by 2031, growing at a CAGR of 5.1% during the forecast period 2024-2031.

Bone growth stimulators improve the body's bone healing process in patients undergoing bone fusion surgery. These stimulators can be worn outside or used during implantation therapies such as cardiac resynchronization therapy(CRT), & implantable cardioverter defibrillators (ICD). It can heal bone fractures by applying electrical or ultrasound waves. This non-invasive bone healing treatment method is an alternative to bone grafts.

The growth of this market is driven by the increasing preference for minimally invasive treatments, rising cases of bone fractures and spinal injuries, increasing geriatric population and subsequent increase in the cases of orthopedic disease and injuries, and growing incidences of sports injuries.

In addition, the growing number of hospitals and surgical centers worldwide, increasing utilization of platelet and rich plasma (PRP) in other applications, and emerging economies offer opportunities for the growth of this market.

Market Dynamics: Drivers

Growing Demand for the Non-Invasive and Minimally Invasive Surgeries Treatments

The demand for the global bone growth stimulators market is driven by multiple factors. One of the key factors is that patients are increasingly opting for non-invasive and minimally invasive surgical treatments due to their benefits over traditional procedures, such as fewer complications, shorter hospitalization, reduced pain, lower risk of infections, and faster recovery.

Moreover, major players in the industry introduced innovative platforms and technologies that would propel this market growth. For instance, in May 2023, Orthofix Medical Inc., a prominent company specializing in spine and orthopedic solutions, declared that its STIM onTrack mobile app received an award for the "Best Patient Engagement Mobile App" from MedTech Breakthrough.

Also, in April 2023, Orthofix Medical, an eminent company in the spine and orthopedics sector, introduced two access retractor systems tailored for minimally invasive spine (MIS) procedures. The launch of the Lattus lateral access system and the Fathom pedicle-based retractor system upgrades the company's portfolio of access solutions.

Restraints

Factors such as product recalls, high cost of treatment and diagnosis, stringent approval process, limited medical reimbursement policies, adverse effects of BMP-based therapy, and limited awareness among people are expected to hamper the market.

Segment Analysis

The global bone growth stimulators market is segmented based on product, application, end-user, and region.

The spinal fusion surgeries segment accounted for approximately 55.8% of the global bone growth stimulators market share

The spinal fusion surgeries segment is expected to hold the largest market share over the forecast period. An electrical bone growth stimulator is a supplemental form of therapy for spinal fusion surgery. It may be used as an adjunct to spinal fusion surgery to help enhance the chances of achieving a successful bone fusion.

Furthermore, major key players in the industry introduce people awareness publications and device approvals help to drive this market growth. For instance, in December 2023, Orthofix Medical Inc. announced the publication of new data from a prospective, multicenter study investigating Pulsed Electromagnetic Field (PEMF) stimulation as an adjunct therapy to lumbar spinal fusion procedures in patients at risk for pseudarthrosis.

For the same source, the SpinalStim device is the only bone growth stimulation therapy system that is FDA-approved as both an adjunct treatment for lumbar spinal fusion and as a nonsurgical treatment for spinal pseudarthrosis.

Similarly, in April 2024, the Xstim received premarket approval from the US Food and Drug Administration (FDA) for its Xstim spine fusion stimulator. Xstim's spinal fusion device is a wearable non-invasive bone growth stimulation device that emits a low-energy signal that promotes bone healing in patients following spinal fusion surgery.

Geographical Analysis

North America accounted for approximately 42.4% of the global bone growth stimulators market share

North America region is expected to hold the largest market share over the forecast period. The growing incidence of orthopedic conditions, such as osteoporosis, osteoarthritis, and sports-related injuries, is expanding the target patient population for bone growth stimulators in this region.

Osteoarthritis is regarded as one of the most common articular diseases among people over the age of 65. According to the Centers for Disease Control and Prevention (CDC), an estimated 63 million Americans have arthritis, with that number expected to rise to 78 million by 2040.

In this region, major key player's presence and product approvals propel this market growth. For instance, in May 2022, Orthofix Medical Inc. (US) obtained FDA premarket approval for the AccelStim bone growth stimulation device.

This approval signifies that the device has met the necessary regulatory requirements and can now be marketed and sold in the United States. The AccelStim bone growth stimulation device is expected to offer advanced therapeutic options for promoting bone healing and treating fractures effectively.

COVID-19 Impact Analysis

The COVID-19 pandemic significantly impacted the global bone growth stimulators market. The pandemic caused a sudden drop in elective surgeries, which is a significant contributor to the demand for bone growth stimulators.

Many orthopedic clinics were temporarily shut down or operated at reduced capacity, further reducing the demand for bone growth stimulators. The pandemic drastically promoted the disease burden and bundled the healthcare systems with a high influx of coronavirus-infected patients, thereby hampering other medical services, including bone growth stimulation treatments.

Market Segmentation

By Product

Implanted Bone Growth Stimulators

Ultrasonic Bone Growth Stimulators

External Bone Growth Stimulators (Combined Magnetic Field (CMF) Devices

Pulsed Electromagnetic Field (PEMF) Devices

Capacitive Coupling (CC) Devices)

Non-Invasive Bone Growth Stimulators

Invasive Bone Growth Stimulators

Others

By Application

Spinal Fusion Surgeries

Trauma Injury and Fractures

Osteogenesis

Oral and Maxillofacial Surgeries

Delayed Union & Nonunion Bone Fractures

Others

By End-Users

Orthopedic Clinics

Hospitals

Ambulatory Surgical Centers

Academic & Research Institutes

Home Care

Others

By Region

North America

U.S.

Canada

Mexico

Europe

Germany

U.K.

France

Spain

Italy

Rest of Europe

South America

Brazil

Argentina

Rest of South America

Asia-Pacific

China

India

Japan

South Korea

Rest of Asia-Pacific

Middle East and Africa

Competitive Landscape

The major global players in the bone growth stimulators market include Zimmer Biomet, Orthofix Medical Inc., Enovis Corporation, ZimVie Inc., OssaTechnics, Kinex Medical Company, LLC, VQ OrthoCare, SIG Orthopaedic, Elizur, and IGEA S.p.A. among others.

Key Developments

In November 2023, Simulare Medical announced the launch of the Alveolar Bone Graft (ABG) simulator, the latest high-fidelity surgical item in its growing line of cleft surgery simulators.

In November 2022, DJO, LLC proclaimed the achievement of the bone growth stimulation device industry from OrthoLogic Corporation.

In August 2022, Theragen is pleased to announce the issuance of a U.S. Patent acknowledging its innovative approach to the development of the ActaStim-S Spine Fusion bone growth stimulator system.

Why Purchase the Report?

To visualize the global bone growth stimulators market segmentation based on product, application, end-user, and region, as well as understand key commercial assets and players.

Identify commercial opportunities by analyzing trends and co-development

Excel data sheet with numerous data points of global bone growth stimulators market level with all segments.

PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.

Product mapping is available in excel consisting of key products of all the major players.

The global bone growth stimulators market report would provide approximately 62 tables, 63 figures, and 182 Pages.

Target Audience 2024

Manufacturers/ Buyers

Industry Investors/Investment Bankers

Research Professionals

Emerging Companies

Table of Contents

1. Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

  • 3.1. Snippet by Product
  • 3.2. Snippet by Application
  • 3.3. Snippet by End-User
  • 3.4. Snippet by Region

4. Dynamics

  • 4.1. Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. Growing Demand for the Non-Invasive and Minimally Invasive Surgeries Treatments
      • 4.1.1.2. Technological Advancements in Healthcare
      • 4.1.1.3. Rising Geriatric population
      • 4.1.1.4. Rising Burden of Bone and Joint Disorders
      • 4.1.1.5. Rising Number of Sports and Accident-Related Orthopedic Injuries
    • 4.1.2. Restraints
      • 4.1.2.1. Product Recalls
      • 4.1.2.2. High Cost of the Treatment & Diagnosis
    • 4.1.3. Opportunity
    • 4.1.4. Impact Analysis

5. Industry Analysis

  • 5.1. Porter's Five Force Analysis
  • 5.2. Supply Chain Analysis
  • 5.3. Pricing Analysis
  • 5.4. Regulatory Analysis
  • 5.5. Unmet Needs
  • 5.6. PESTEL Analysis
  • 5.7. Patent Analysis
  • 5.8. SWOT Analysis

6. COVID-19 Analysis

  • 6.1. Analysis of COVID-19
    • 6.1.1. Scenario Before COVID
    • 6.1.2. Scenario During COVID
    • 6.1.3. Scenario Post COVID
  • 6.2. Pricing Dynamics Amid COVID-19
  • 6.3. Demand-Supply Spectrum
  • 6.4. Government Initiatives Related to the Market During the Pandemic
  • 6.5. Manufacturers Strategic Initiatives
  • 6.6. Conclusion

7. By Product

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
    • 7.1.2. Market Attractiveness Index, By Product
  • 7.2. Implanted Bone Growth Stimulators*
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 7.3. Ultrasonic Bone Growth Stimulators
  • 7.4. External Bone Growth Stimulators (Combined Magnetic Field (CMF) Devices
  • 7.5. Pulsed Electromagnetic Field (PEMF) Devices
  • 7.6. Capacitive Coupling (CC) Devices)
  • 7.7. Non-Invasive Bone Growth Stimulators
  • 7.8. Invasive Bone Growth Stimulators
  • 7.9. Others

8. By Application

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 8.1.2. Market Attractiveness Index, By Application
  • 8.2. Spinal Fusion Surgeries*
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 8.3. Trauma Injury and Fractures
  • 8.4. Osteogenesis
  • 8.5. Oral and Maxillofacial Surgeries
  • 8.6. Delayed Union & Nonunion Bone Fractures
  • 8.7. Others

9. By End-User

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 9.1.2. Market Attractiveness Index, By End-User
  • 9.2. Orthopedic Clinics *
    • 9.2.1. Introduction
    • 9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 9.3. Hospitals
  • 9.4. Ambulatory Surgical Centers
  • 9.5. Academic & Research Institutes
  • 9.6. Home Care
  • 9.7. Others

10. By Region

  • 10.1. Introduction
    • 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
    • 10.1.2. Market Attractiveness Index, By Region
  • 10.2. North America
    • 10.2.1. Introduction
    • 10.2.2. Key Region-Specific Dynamics
    • 10.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
    • 10.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 10.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.2.6.1. U.S.
      • 10.2.6.2. Canada
      • 10.2.6.3. Mexico
  • 10.3. Europe
    • 10.3.1. Introduction
    • 10.3.2. Key Region-Specific Dynamics
    • 10.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
    • 10.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 10.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.3.6.1. Germany
      • 10.3.6.2. UK
      • 10.3.6.3. France
      • 10.3.6.4. Italy
      • 10.3.6.5. Spain
      • 10.3.6.6. Rest of Europe
  • 10.4. South America
    • 10.4.1. Introduction
    • 10.4.2. Key Region-Specific Dynamics
    • 10.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
    • 10.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 10.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.4.6.1. Brazil
      • 10.4.6.2. Argentina
      • 10.4.6.3. Rest of South America
  • 10.5. Asia-Pacific
    • 10.5.1. Introduction
    • 10.5.2. Key Region-Specific Dynamics
    • 10.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
    • 10.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 10.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.5.6.1. China
      • 10.5.6.2. India
      • 10.5.6.3. Japan
      • 10.5.6.4. South Korea
      • 10.5.6.5. Rest of Asia-Pacific
  • 10.6. Middle East and Africa
    • 10.6.1. Introduction
    • 10.6.2. Key Region-Specific Dynamics
    • 10.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
    • 10.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User

11. Competitive Landscape

  • 11.1. Competitive Scenario
  • 11.2. Market Positioning/Share Analysis
  • 11.3. Mergers and Acquisitions Analysis

12. Company Profiles

  • 12.1. Zimmer Biomet *
    • 12.1.1. Company Overview
    • 12.1.2. Product Portfolio & Description
    • 12.1.3. Financial Overview
    • 12.1.4. Key Developments
  • 12.2. Orthofix Medical Inc
  • 12.3. Enovis Corporation
  • 12.4. ZimVie Inc
  • 12.5. OssaTechnics
  • 12.6. Kinex Medical Company, LLC
  • 12.7. VQ OrthoCare
  • 12.8. SIG Orthopaedic
  • 12.9. Elizur
  • 12.10. IGEA S.p.A. (LIST NOT EXHAUSTIVE)

13. Appendix

  • 13.1. About Us and Services
  • 13.2. Contact Us